Zacks Research Issues Negative Estimate for PAHC Earnings

Phibro Animal Health Co. (NASDAQ:PAHC) – Zacks Research cut their Q3 2025 EPS estimates for shares of Phibro Animal Health in a research report issued on Wednesday, November 20th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $0.35 for the quarter, down from their previous estimate of $0.37. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.61 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q1 2026 earnings at $0.32 EPS, Q3 2026 earnings at $0.33 EPS and Q1 2027 earnings at $0.48 EPS.

Phibro Animal Health (NASDAQ:PAHC) last posted its quarterly earnings data on Wednesday, August 28th. The company reported $0.41 earnings per share for the quarter, topping analysts’ consensus estimates of $0.34 by $0.07. The company had revenue of $273.16 million for the quarter, compared to analyst estimates of $262.44 million. Phibro Animal Health had a net margin of 1.67% and a return on equity of 21.59%.

A number of other equities analysts have also recently issued reports on PAHC. Bank of America boosted their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a report on Friday, August 30th. Barclays boosted their target price on shares of Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. JPMorgan Chase & Co. started coverage on shares of Phibro Animal Health in a report on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price target on the stock. Finally, StockNews.com lowered shares of Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Wednesday, November 20th. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus price target of $16.50.

Phibro Animal Health Stock Down 1.7 %

Shares of NASDAQ:PAHC opened at $23.73 on Monday. The company has a debt-to-equity ratio of 1.81, a current ratio of 3.23 and a quick ratio of 1.69. The business has a 50 day simple moving average of $23.24 and a two-hundred day simple moving average of $20.12. Phibro Animal Health has a 1 year low of $9.49 and a 1 year high of $25.98. The firm has a market capitalization of $961.14 million, a PE ratio of 55.19, a price-to-earnings-growth ratio of 0.61 and a beta of 0.51.

Hedge Funds Weigh In On Phibro Animal Health

A number of large investors have recently bought and sold shares of the business. CWM LLC raised its holdings in Phibro Animal Health by 89.8% in the second quarter. CWM LLC now owns 2,188 shares of the company’s stock worth $37,000 after purchasing an additional 1,035 shares in the last quarter. Quantbot Technologies LP bought a new position in shares of Phibro Animal Health during the 3rd quarter worth approximately $70,000. nVerses Capital LLC bought a new position in shares of Phibro Animal Health during the 3rd quarter worth approximately $70,000. China Universal Asset Management Co. Ltd. lifted its position in Phibro Animal Health by 63.7% during the third quarter. China Universal Asset Management Co. Ltd. now owns 3,912 shares of the company’s stock valued at $88,000 after acquiring an additional 1,522 shares during the last quarter. Finally, Summit Securities Group LLC acquired a new stake in Phibro Animal Health in the second quarter valued at approximately $83,000. Institutional investors own 99.34% of the company’s stock.

Insider Activity

In other Phibro Animal Health news, Director E Thomas Corcoran acquired 5,000 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were purchased at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the completion of the purchase, the director now owns 25,000 shares in the company, valued at approximately $500,500. This trade represents a 25.00 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Insiders own 50.07% of the company’s stock.

Phibro Animal Health Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th will be given a dividend of $0.12 per share. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.02%. The ex-dividend date is Wednesday, November 27th. Phibro Animal Health’s payout ratio is 111.63%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.